Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Am J Cardiol. 2014 Oct 16;115(1):118–124. doi: 10.1016/j.amjcard.2014.09.054

Table 2.

Characteristics of operative and trans-catheter pulmonary valve replacement subgroups

Operative valve replacement Trans-catheter valve replacement p
Number 769 at 35 centers 30 at 18 centers
Age at pulmonary valve replacement (years) 17 (range: 10–61 IQR: 13–22) 20.5 (range: 10–64, IQR: 15–28) 0.046
Female Gender 333 (43%) 15 (50%) 0.46
Race
White 574 (76%) 19 (63%) 0.04
Black 71 (9%) 7 (23%)
Asian 25 (3%) 2 (7%)
Other 91 (12%) 2 (7%)
Known genetic syndrome 76 (10%) 3 (10%) 1.0
Payer
Private insurance 450 (59%) 17 (57%) 0.34
Medicaid 207 (27%) 6 (20%)
Other 112 (15%) 7 (23%)
Mortality 7 (0.9%) 0 1.0
Cost (2012US$)* 43,877 (range: 4,399–866,720, IQR: 35,294 – 57,045) 47,609 (range: 10,532–89,771, IQR: 35,310–72,024) 0.45
Hospital length of stay (days) 4 (range: 1–126, IQR: 3–5) 1 (range: 1–14, IQR: 1–2) <0.0001
ICU stay (days) 2 (range: 1–41, IQR: 2–4) 2 (range: 1–4, IQR: 1.5–3) 0.21
*

n=713 for SVR and n=26 for TVR

n=648 for SVR and n=8 for TVR

Abbreviations: ICU: Intensive care unit, IQR inter-quartile range, 2012US$ United States dollars adjusted for inflation to year 2012